A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases

被引：29
作者：
Khandani, Amir H.
Calvo, Benjamin F.
O'Neil, Bert H.
Jorgenson, Jennifer
Mauro, Matthew A.
机构：
[1] Univ N Carolina, Sch Med, Dept Radiol, Nucl Med Sect, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Dept Surg, Div Surg Oncol, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Dept Med, Div Hematol Oncol, Chapel Hill, NC USA
[5] Univ N Carolina, Sch Med, Dept Radiol, Sect Vasc & Intervent Biol, Chapel Hill, NC USA
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2007年 / 189卷 / 05期
关键词：
FDG PET; liver cancer; liver metastasis; metastases; oncologic imaging; radiofrequency ablation;
D O I：
10.2214/AJR.07.2126
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The objective of our study was to collect pilot data about the use of FDG PET within hours after radiofrequency ablation (RFA) of liver metastases. CONCLUSION. Total photopenia on early PET can potentially be regarded as a macroscopic tumor-free margin; focal uptake can be regarded as macroscopic residual tumor.
引用
收藏
页码：1199 / 1202
页数：4
相关论文
共 10 条
[1]   FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation [J].
Anderson, GS ;
Brinkmann, F ;
Soulen, MC ;
Alavi, A ;
Zhuang, HM .
CLINICAL NUCLEAR MEDICINE, 2003, 28 (03) :192-197
[2]  
Antoch G, 2005, J NUCL MED, V46, P520
[3]   [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases [J].
Donckier, V ;
Van Laethem, JL ;
Goldman, S ;
Van Gansbeke, D ;
Feron, P ;
Ickx, B ;
Wikler, D ;
Gelin, M .
JOURNAL OF SURGICAL ONCOLOGY, 2003, 84 (04) :215-223
[4]  
Halpern BS, 2004, J NUCL MED, V45, P797
[5]   Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: A prospective study [J].
Langenhoff, BS ;
Oyen, WJG ;
Jager, GJ ;
Strijk, SP ;
Wobbes, T ;
Corstens, FHM ;
Ruers, TJM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (22) :4453-4458
[6]  
McGahan J P, 1992, J Vasc Interv Radiol, V3, P291, DOI 10.1016/S1051-0443(92)72028-4
[7]   Radiofrequency ablation of the liver: Current status [J].
McGahan, JP ;
Dodd, GD .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (01) :3-16
[8]   Time-related changes of radiofrequency ablation lesion in the normal rabbit liver: Findings of magnetic resonance imaging and histopathology [J].
Tsuda, M ;
Rikimaru, H ;
Majima, K ;
Yamada, T ;
Saito, H ;
Ishibashi, T ;
Takahashi, S ;
Miyachi, H ;
Endoh, M ;
Yamada, S .
INVESTIGATIVE RADIOLOGY, 2003, 38 (08) :525-531
[9]   Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results [J].
Veit, P ;
Antoch, G ;
Stergar, H ;
Bockisch, A ;
Forsting, M ;
Kuehl, H .
EUROPEAN RADIOLOGY, 2006, 16 (01) :80-87
[10]   Positron emission tomography as an imaging biomarker [J].
Weber, Wolfgang A. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) :3282-3292
1